Can someone who knows the UK approval process expl
Post# of 148190
I know people have talked about the different between "route to approval" and "route to market" as a possible indicator that leronlimab is in a potentially good position.
I am just looking for someone with an understanding of the MHRA to help set realistic expectations. Thanks in advance.